Interferon‐γ‐inducible protein 10 augments atopic dermatitis via amplifying Th2 immune response.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      This article explores the role of interferon‐γ‐inducible protein 10 (IP‐10) in atopic dermatitis (AD), a Th2-dominant skin disease. The study found that IP-10 expression was elevated in the lesional tissues of AD patients and in mouse models of AD. The researchers also investigated the function of IP-10 in AD pathogenesis by using IP-10 knockout mice and injecting recombinant IP-10 into AD models. They observed that IP-10 played a role in promoting Th2 immune responses and exacerbating AD symptoms. The study suggests that IP-10 could be a potential therapeutic target for AD treatment. [Extracted from the article]
    • Abstract:
      Copyright of Allergy is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)